Circulating miRNAs and extracellular vesicle containing miRNAs as response biomarkers of anti PD-1/PD-L1 therapy in non-small-cell lung cancer.

[1]  David L Rimm,et al.  Comparison of Biomarker Modalities for Predicting Response to PD-1/PD-L1 Checkpoint Blockade: A Systematic Review and Meta-analysis. , 2019, JAMA oncology.

[2]  J. Wolchok,et al.  Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies. , 2018, Cancer cell.

[3]  David J. Galas,et al.  sRNAnalyzer—a flexible and customizable small RNA sequencing data analysis pipeline , 2017, Nucleic acids research.

[4]  F. Ossendorp,et al.  PD-L1 expression on malignant cells is no prerequisite for checkpoint therapy , 2017, Oncoimmunology.

[5]  D. Carbone,et al.  Relationship between Overall Survival and Response or Progression‐Free Survival in Advanced Non–Small Cell Lung Cancer Patients Treated with Anti–PD‐1/PD‐L1 Antibodies , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[6]  D. Carbone,et al.  Predictive Markers for the Efficacy of Anti-PD-1/PD-L1 Antibodies in Lung Cancer. , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[7]  Yong Peng,et al.  The role of MicroRNAs in human cancer , 2016, Signal Transduction and Targeted Therapy.

[8]  Muneesh Tewari,et al.  Quantitative and stoichiometric analysis of the microRNA content of exosomes , 2014, Proceedings of the National Academy of Sciences.

[9]  P. Robbins,et al.  Regulation of immune responses by extracellular vesicles , 2014, Nature Reviews Immunology.

[10]  W. Dong,et al.  High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer. , 2013, European journal of cancer.

[11]  Xiao-guang Liu,et al.  Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients , 2012, Medical Oncology.

[12]  K. Vickers,et al.  MicroRNAs are Transported in Plasma and Delivered to Recipient Cells by High-Density Lipoproteins , 2011, Nature Cell Biology.

[13]  Chi-Ying F. Huang,et al.  miRTarBase: a database curates experimentally validated microRNA–target interactions , 2010, Nucleic Acids Res..

[14]  Jessica A. Weber,et al.  Export of microRNAs and microRNA-protective protein by mammalian cells , 2010, Nucleic acids research.

[15]  Inyoul Y. Lee,et al.  Circulating miRNAs as Tumor Biomarkers , 2019, Oncogenomics.

[16]  D. Galas,et al.  Preparation of Small RNA NGS Libraries from Biofluids. , 2018, Methods in molecular biology.

[17]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.